Adalimumab (uveitis): Injection 20 mg in 0.2 mL pre filled syringe, Injection 40 mg in 0.4 mL pre filled syringe, Injection 40 mg in 0.4 mL pre filled pen, Injection 80 mg 0.8 mL pre filled syringe, Injection 80 mg in 0.8 mL pre filled pen; Humira^®

Page last updated: 5 July 2024

• Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 1.3MB)
• Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 708KB)